Global Exporter & Bulk Supplier of Alimlieva 100 mg Injection
🌍 Introduction
Are you looking for a trusted and globally compliant exporter of Alimlieva 100 mg Injection? At Ernest Oncology (a division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the secure, compliant, and efficient supply chain management and distribution of critical oncology formulations, including Pemetrexed 100 mg injections, to hospitals, pharmacies, and pharmaceutical distributors worldwide.
🔬 1. Product Overview: Alimlieva 100 mg Injection
Alimlieva 100 mg Injection contains Pemetrexed, a multi-targeted folate antimetabolite antineoplastic agent widely used in combination therapies to treat various types of tumors, especially non-small cell lung cancer.
Composition: Pemetrexed Disodium equivalent to Pemetrexed 100 mg
Therapeutic Class: Anti-folate antineoplastic agent / Antimetabolite
Formulation Type: Lyophilized powder for sterile Intravenous (IV) infusion
Storage Temperature: Store below 25°C.
Protect from light. Do not freeze.
⚙️ 2. Mechanism of Action
Alimlieva functions as an antifolate agent that interferes with the metabolic and genetic processes of cancer cells:
Enzyme Inhibition: Pemetrexed inhibits key folate-dependent enzymes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT).
Interruption of Synthesis: This binding blocks the synthesis of purine and pyrimidine nucleotides that are required for DNA and RNA replication.
Apoptosis: The unrepairable genetic damage triggers cell death (apoptosis) in rapidly dividing malignant cells.
🏥 3. Therapeutic Indications
Alimlieva 100 mg Injection is indicated for:
Non-Small Cell Lung Cancer (NSCLC): Used as a first-line, maintenance, or second-line treatment for advanced or metastatic non-squamous non-small cell lung cancer.
Malignant Pleural Mesothelioma: Indicated in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.
⚠️ 4. Administration & Safety Guidelines
Route of Administration: Alimlieva is administered exclusively via slow Intravenous (IV) infusion over 10 minutes following proper reconstitution.
Pre-medication: To reduce toxicity, patients should be pre-treated with folic acid, vitamin B12, and a corticosteroid before the infusion.
Side Effects & Precautions: Common side effects include nausea, vomiting, diarrhea, loss of appetite, fatigue, and rash.
Serious risks include bone marrow suppression, renal impairment, and fetal harm (effective contraception required during therapy).
🛡️ Prescription Status & Disclaimer
PRESCRIPTION MEDICINE IS YES
Disclaimer: Alimlieva 100 mg Injection is a prescription chemotherapy drug.
It must be administered strictly under the supervision of a qualified oncologist or healthcare professional in a clinical setting. Ernest Oncology supplies these medications in full compliance with all applicable international pharmaceutical export laws and regulations.
📞 Contact Ernest Oncology — Medicine Export
(GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.)
🌐 Websites:
📧 Email Inquiries: exports@ernestpharmaceuticals.com
📲 Call / WhatsApp: +91 93599 02383 | +91 94054 76170
🔗 WhatsApp Direct Link:
https://wa.me/919359902383
